CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The Role of Neutrophil-to-Lymphocyte Ratio in Predicting Pathological Response for Resectable Non–Small Cell Lung Cancer Treated with Neoadjuvant Chemotherapy Combined with PD-1 Checkpoint Inhibitors
Xiaoyan Sun, Yingnan Feng, Bin Zhang, Wuhao Huang, Xiaoliang Zhao, Hua Zhang, Dongsheng Yue, Changli Wang
Cancer Research and Treatment. 2022;54(4):1017-1029.   Published online 2021 November 23    DOI: https://doi.org/10.4143/crt.2021.1007

Excel Download

The Role of Neutrophil-to-Lymphocyte Ratio in Predicting Pathological Response for Resectable Non–Small Cell Lung Cancer Treated with Neoadjuvant Chemotherapy Combined with PD-1 Checkpoint Inhibitors
Cancer Research and Treatment. 2022;54(4):1017-1029   Crossref logo
Link1 Link2 Link3

The role of pretreatment neutrophil/lymphocyte ratio in predicting survival in pancreatic cancer patients based on neoadjuvant chemotherapy pathological response
HPB. 2018;20:S40   Crossref logo
Link1 Link2

Prognostic significance of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors
Annals of Oncology. 2019;30:i3   Crossref logo
Link1 Link2 Link3

Neutrophil-to-lymphocyte ratio (NLR) trends and treatment response to programmed death/ligand 1 (PD-1/PD-L1) inhibitors in non-small cell lung cancer (NSCLC)
Lung Cancer. 2019;127:S41-S42   Crossref logo
Link1 Link2

Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis
International Immunopharmacology. 2020;85:106677   Crossref logo
Link1 Link2

Pathologic response and safety to neoadjuvant PD-1 inhibitors and chemotherapy in resectable squamous non-small-cell Lung cancer
Frontiers in Oncology. 2022;12:   Crossref logo
Link1

The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer
Journal of Breast Cancer. 2019;22(3):425   Crossref logo
Link1 Link2 Link3

Perspectives: Neutrophil-to-lymphocyte Ratio as a Potential Biomarker in Immune Checkpoint Inhibitor for Non–Small-Cell Lung Cancer
Clinical Lung Cancer. 2019;20(3):143-147   Crossref logo
Link1 Link2

An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer
Lung Cancer. 1995;12(1-2):151   Crossref logo
Link1 Link2

The Predictive Value of Pretreatment Lactate Dehydrogenase and Derived Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors: A Meta-Analysis
Frontiers in Oncology. 2022;12:   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.